AbCellera (NASDAQ: ABCL) shareholders back directors, auditor and Say-on-Pay
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
AbCellera Biologics Inc. reported the results of its annual shareholder meeting held on June 11, 2026. Shareholders elected Class III directors John S. Montalbano and Stephen R. Quake to terms ending at the 2029 annual meeting. As of the April 15, 2026 record date, 305,264,947 common shares were outstanding and entitled to vote.
Shareholders also ratified Ernst & Young LLP as independent registered public accounting firm for the year ending December 31, 2026, and approved, on a non-binding advisory basis, the compensation of the company’s named executive officers (Say-on-Pay). No other matters were submitted for a vote.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Shares entitled to vote: 305,264,947 shares
Votes for Montalbano: 141,430,732 for
Votes for Quake: 149,019,960 for
+4 more
7 metrics
Shares entitled to vote
305,264,947 shares
Common shares outstanding as of April 15, 2026 record date
Votes for Montalbano
141,430,732 for
Election of Class III director John S. Montalbano, CFA
Votes for Quake
149,019,960 for
Election of Class III director Stephen R. Quake, D.Phil.
Broker non-votes Proposal 1
36,576,359 shares
Broker non-votes on director election proposal
Auditor ratification for votes
189,927,972 for
Ratification of Ernst & Young LLP as 2026 auditor
Say-on-Pay for votes
142,831,950 for
Advisory approval of named executive officer compensation
Say-on-Pay broker non-votes
36,576,359 shares
Broker non-votes on Proposal 3
Key Terms
Annual Meeting of Shareholders, Class III directors, independent registered public accounting firm, non-binding advisory basis, +2 more
6 terms
Class III directors financial
"to elect John S. Montalbano, CFA, and Stephen R. Quake, D.Phil., as Class III directors"
Class III directors are members of a company’s board assigned to one of several staggered term groups, so only that class faces election in a particular year while other classes stay in place. For investors this affects corporate control and takeover risk because staggered elections make it slower and harder for an outside group to replace a majority of directors quickly—think of it as a rotating schedule for board seats that provides continuity but can also entrench existing leadership.
independent registered public accounting firm financial
"to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
non-binding advisory basis financial
"to approve on a non-binding advisory basis, the compensation of the Company’s named executive offices"
A non-binding advisory basis is guidance or a recommendation offered for informational purposes that does not create legal obligations or guarantees; recipients can accept, modify, or ignore it without contractual consequences. Investors should treat it like a weather forecast for planning—useful for forming expectations and assessing risk, but not a firm promise—so they should verify assumptions, seek confirming information, and avoid relying on it as the sole basis for investment decisions.
Say-on-Pay financial
"the compensation of the Company’s named executive offices, or Say-on-Pay (“Proposal 3”)"
A say-on-pay is a shareholder vote that gives investors a chance to approve or disapprove a company’s executive compensation packages, typically held at annual meetings. It matters because the vote signals investor satisfaction with how leaders are paid—like customers rating how well managers are rewarded—and can push boards to change pay plans, reducing governance risk and affecting investor confidence and stock value even though the vote is usually advisory rather than legally binding.
broker non-votes financial
"The broker non-votes for this Proposal 1 totaled 36,576,359 common shares"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
FAQ
Who was elected to AbCellera Biologics Inc. (ABCL) board at the 2026 annual meeting?
Shareholders elected John S. Montalbano, CFA, and Stephen R. Quake, D.Phil., as Class III directors. They will serve three-year terms expiring at the 2029 annual meeting, continuing in office until their successors are elected and qualified.
Was AbCellera Biologics Inc. (ABCL) Say-on-Pay proposal approved in 2026?
Yes. The non-binding advisory Say-on-Pay proposal on named executive officer compensation was approved. Votes were 142,831,950 for, 10,932,105 against, and 435,917 abstaining, with 36,576,359 broker non-votes reported for this proposal.
Were there any other matters voted on at AbCellera (ABCL) 2026 annual meeting?
No. The company reported that no other matters were submitted to, or voted on by, shareholders at the annual meeting beyond director elections, auditor ratification, and the advisory Say-on-Pay proposal.